BHC - Bausch Health Companies Inc.

QQQ $ 439.97 $ 3.02 (0.69 %)

DIA $ 388.40 $ 1.63 (0.42 %)

SPY $ 516.34 $ 5.05 (0.99 %)

TLT $ 90.16 $ 0.32 (0.36 %)

GLD $ 215.21 $ 2.25 (1.06 %)

Previous Close

$ 7.52

Open

$ 7.88

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 7.47 - $ 7.97

52 Week Range

$ 5.57 - $ 11.46

Volume

3,396,646

Average Volume

Market Cap

2.87B

Beta (5Y Monthly)

$ 1.38

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-02-2024	03-31-2024	10-Q
2	02-22-2024	12-31-2023	10-K
3	11-02-2023	09-30-2023	10-Q
4	08-03-2023	06-30-2023	10-Q
5	05-04-2023	03-31-2023	10-Q
6	02-23-2023	12-31-2022	10-K
7	11-03-2022	09-30-2022	10-Q
8	08-09-2022	06-30-2022	10-Q
9	05-10-2022	03-31-2022	10-Q
10	02-23-2022	12-31-2021	10-K
11	11-02-2021	09-30-2021	10-Q
12	08-03-2021	06-30-2021	10-Q
13	05-04-2021	03-31-2021	10-Q
14	02-24-2021	12-31-2020	10-K
15	11-03-2020	09-30-2020	10-Q
16	08-06-2020	06-30-2020	10-Q
17	05-07-2020	03-31-2020	10-Q
18	02-19-2020	12-31-2019	10-K
19	11-04-2019	09-30-2019	10-Q
20	08-06-2019	06-30-2019	10-Q
21	05-06-2019	03-31-2019	10-Q
22	02-20-2019	12-31-2018	10-K
23	11-06-2018	09-30-2018	10-Q
24	08-07-2018	06-30-2018	10-Q
25	05-08-2018	03-31-2018	10-Q
26	02-28-2018	12-31-2017	10-K
27	11-07-2017	09-30-2017	10-Q
28	08-08-2017	06-30-2017	10-Q
29	05-09-2017	03-31-2017	10-Q
30	03-01-2017	12-31-2016	10-K
31	11-09-2016	09-30-2016	10-Q
32	08-09-2016	06-30-2016	10-Q
33	06-07-2016	03-31-2016	10-Q
34	04-29-2016	12-31-2015	10-K
35	10-26-2015	09-30-2015	10-Q
36	07-28-2015	06-30-2015	10-Q
37	04-30-2015	03-31-2015	10-Q
38	02-25-2015	12-31-2014	10-K
39	10-24-2014	09-30-2014	10-Q
40	08-01-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Why Bausch Health Companies Shares Are Fal...
05/02/2024 17:48:02

Bausch Health misses Q1 EPS estimates at 59 cents, despite a revenue increase of 11%.

Bausch Health Companies Reaffirms 2024 Rev...
05/02/2024 11:16:34

Bausch Health Companies Q1 Adjusted Net In...
05/02/2024 11:11:54

Bausch Health Companies Q1 Sales $2.153 Mi...
05/02/2024 11:10:20

Bausch Health Companies (NYSE:BHC) reported quarterly sales of $2.153 which missed the analyst consensus estimate of $2.156 bil...

RBC Capital Maintains Sector Perform on Ba...
04/23/2024 15:44:37

RBC Capital analyst Douglas Miehm maintains Bausch Health Companies (NYSE:BHC) with a Sector Perform and lowers the price ta...

RBC Capital Reiterates Sector Perform on B...
04/12/2024 14:15:57

RBC Capital analyst Douglas Miehm reiterates Bausch Health Companies (NYSE:BHC) with a Sector Perform and maintains $12 pric...

U.S. Appeals Court Says Bausch Can Block A...
04/11/2024 15:50:15

- Reuters Citing U.S. Appeals Court

Bausch Health Companies Appeals Court Ruli...
04/11/2024 14:59:30

https://storage.courtlistener.com/recap/gov.uscourts.cafc.19114/gov.uscourts.cafc.19114.71.0.pdf

Acne Vulgaris Treatment PrARAZLO Now Avail...
04/11/2024 12:04:37

Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that its topical prescrip...

Bausch Health Announces Patent Lawsuit Aga...
04/05/2024 22:27:59

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) along with its gastroenterology business, Salix Pharmaceuticals, Inc., announc...

RBC Capital Maintains Sector Perform on Ba...
04/05/2024 11:21:10

RBC Capital analyst Douglas Miehm maintains Bausch Health Companies (NYSE:BHC) with a Sector Perform and raises the price ta...

Bausch Health, Canada Announces First Pub...
04/03/2024 12:08:22

Salix Pharmaceuticals Announces Phase 2 In...
03/06/2024 13:05:26

RBC Capital Maintains Sector Perform Ratin...
02/23/2024 17:00:08

RBC Capital Maintains Sector Perform on Ba...
02/23/2024 15:29:57

RBC Capital analyst Douglas Miehm maintains Bausch Health Companies (NYSE:BHC) with a Sector Perform and raises the price ta...

Bausch Health Companies Forecasts 2024 Rev...
02/22/2024 12:15:20

Bausch Health Companies Q4 Sales $2.41B Be...
02/22/2024 12:12:52

Bausch Health Companies (NYSE:BHC) reported quarterly sales of $2.41 billion which beat the analyst consensus estimate of $2.30...

Earnings Scheduled For February 22, 2024
02/22/2024 10:27:06

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on reve...

Preview: Bausch Health Companies's Earnings
02/21/2024 15:01:44

a-toxic-byproduct-of-an-imperfect-higher-education-system--famous-short-seller-known-as-the-assassin-strikes-her-newest-target

A 'Toxic Byproduct of an Imperfect Higher ...
02/08/2024 13:59:14